BioStock: Saniona's CEO comments on the collaboration with AstronauTx
Saniona has entered into a new research collaboration with AstronauTx in Alzheimer's disease and other neurodegenerative conditions. Saniona may receive up to SEK 1.9 billion or $177 million in milestone payments, as well as royalties on worldwide net sales of resulting products under the collaboration. BioStock talked to Saniona's CEO Thomas Feldthus to learn more.
Read the full interview with Saniona's CEO Thomas Feldthus at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/